GALWAY, IRELAND--October 26, 2022--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)-- Eli Lilly (NYSE:LLY) (Indianapolis, Indiana) has been granted planning permission to construct a 400 million-euro (US$390 million) cell therapy manufacturing plant in County Limerick, Ireland.

Within this article: Details permit for new plant, capacity, investment, products, existing operations